{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T11:48:39Z","timestamp":1725277719151},"reference-count":80,"publisher":"Wiley","issue":"S10","license":[{"start":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T00:00:00Z","timestamp":1416182400000},"content-version":"vor","delay-in-days":16,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Journal of Australia"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.5694\/mja14.01155","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T06:44:12Z","timestamp":1429253052000},"source":"Crossref","is-referenced-by-count":2,"title":["Optimising pharmacotherapy for secondary prevention of non\u2010invasively managed acute coronary syndrome"],"prefix":"10.5694","volume":"201","author":[{"given":"Peter L","family":"Thompson","sequence":"first","affiliation":[{"name":"School of Medicine and Pharmacology, University of Western Australia, Perth, WA."},{"name":"Sir Charles Gairdner Hospital, Perth, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angus G","family":"Thompson","sequence":"additional","affiliation":[{"name":"Sir Charles Gairdner Hospital, Perth, WA."},{"name":"HeartCare WA, Perth, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Judkins","sequence":"additional","affiliation":[{"name":"Fremantle Hospital, Perth, WA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,17]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.11854"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr236"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e31828478ac"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.hlc.2011.03.008","article-title":"2011 Addendum to the National Heart Foundation of Australia\/Cardiac Society of Australia and New Zealand Guidelines for the management of acute coronary syndromes (ACS) 2006","volume":"20","author":"Chew DP","year":"2011","journal-title":"Heart Lung Circ"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2011.tb03237.x"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.324.7329.71"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2011.05.020"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000091201.39590.CB"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1056\/NEJMoa0909475","article-title":"Dose comparisons of clopidogrel and aspirin in acute coronary syndromes","volume":"363","author":"CURRENT\u2010OASIS 7 Investigators, Mehta SR, Bassand JP, et al","year":"2010","journal-title":"N Engl J Med"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18325"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.15.1684"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010746"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.12.019"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2010.07.038"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060989"},{"issue":"1","key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/01.hco.0000409965.20588.c5","article-title":"Responsiveness to P2Y12 receptor inhibitors","volume":"26","author":"Esposito G","year":"2011","journal-title":"Curr Opin Cardiol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.047"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.290"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1209979"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0b013e318202f701"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007964"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302371"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1205512"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904327"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehs215"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-4-200508160-00005"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1112277"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105819"},{"key":"e_1_2_8_31_1","article-title":"2014 AHA\/ACC\/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","author":"January CT","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.029"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)62177-1"},{"key":"e_1_2_8_34_1","volume-title":"Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease","author":"National Institute for Health and Clinical Excellence","year":"2008"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67394-1"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(00)01519-8"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.17.2046"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040583"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.01.067"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.11.1307"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.07.001"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1177\/2047487314525531"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2008.02062.x"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.07.023"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.4030"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.03.019"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199908053410604"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.10.1154"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706628"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1206797"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009744"},{"key":"e_1_2_8_53_1","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"AIM\u2010HIGH Investigators, Boden WE, Probstfield JL, et al","year":"2011","journal-title":"N Engl J Med"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht055"},{"key":"e_1_2_8_55_1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/HCO.0b013e328362210d","article-title":"High\u2010density lipoprotein cholesterol raising: does it matter?","volume":"28","author":"Schofield JD","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"e_1_2_8_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr362"},{"key":"e_1_2_8_57_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470693926.ch15"},{"key":"e_1_2_8_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.08.001"},{"key":"e_1_2_8_59_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.1.583"},{"key":"e_1_2_8_60_1","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.1982.03320370021023","article-title":"I. Mortality results","volume":"247","author":"A randomized trial of propranolol in patients with acute myocardial infarction","year":"1982","journal-title":"JAMA"},{"key":"e_1_2_8_61_1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1056\/NEJM198104023041401","volume":"304","author":"Timolol\u2010induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction","year":"1981","journal-title":"N Engl J Med"},{"key":"e_1_2_8_62_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.83.2.422"},{"key":"e_1_2_8_63_1","doi-asserted-by":"publisher","DOI":"10.1097\/HCO.0b013e328361e97a"},{"issue":"11","key":"e_1_2_8_64_1","first-page":"CD002003","article-title":"Beta\u2010blockers for hypertension","author":"Wiysonge CS","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_65_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.12559"},{"key":"e_1_2_8_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f55"},{"key":"e_1_2_8_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04560-8"},{"key":"e_1_2_8_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02212-1"},{"key":"e_1_2_8_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.073"},{"key":"e_1_2_8_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu078"},{"key":"e_1_2_8_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032292"},{"key":"e_1_2_8_72_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909023411001"},{"key":"e_1_2_8_73_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030207"},{"key":"e_1_2_8_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040135"},{"key":"e_1_2_8_75_1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9149(90)90351-Z","volume":"66","author":"Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II\u2014DAVIT II)","year":"1990","journal-title":"Am J Cardiol"},{"key":"e_1_2_8_76_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198808183190701"},{"key":"e_1_2_8_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610103351504"},{"key":"e_1_2_8_78_1","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.1993.03510130095038","article-title":"Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials","volume":"270","author":"Teo KK","year":"1993","journal-title":"JAMA"},{"key":"e_1_2_8_79_1","first-page":"669","article-title":"ISIS\u20104 (Fourth International Study of Infarct Survival) Collaborative Group","volume":"345","author":"ISIS\u20104: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction","year":"1995","journal-title":"Lancet"},{"key":"e_1_2_8_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(01)00600-3"},{"key":"e_1_2_8_81_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702203360801"}],"container-title":["Medical Journal of Australia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja14.01155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.5694\/mja14.01155","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.5694\/mja14.01155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T08:52:07Z","timestamp":1651740727000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/abs\/10.5694\/mja14.01155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":80,"journal-issue":{"issue":"S10","published-online":{"date-parts":[[2014,11,17]]},"published-print":{"date-parts":[[2014,11]]}},"alternative-id":["10.5694\/mja14.01155"],"URL":"https:\/\/doi.org\/10.5694\/mja14.01155","archive":["Portico"],"relation":{},"ISSN":["0025-729X","1326-5377"],"issn-type":[{"value":"0025-729X","type":"print"},{"value":"1326-5377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}